Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 1
2011 1
2012 1
2014 1
2015 1
2016 1
2017 2
2018 1
2019 4
2020 10
2021 8
2022 6
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions.
Nishii Y, Sakaguchi T, Esumi S, Esumi M, Nakamura Y, Suzuki Y, Ito K, Fujiwara K, Yasui H, Ito A, Tarukawa T, Tsuruga T, D'Alessandro-Gabazza CN, Yasuma T, Fujimoto H, Asano F, Gabazza EC, Kobayashi T, Taguchi O, Hataji O. Nishii Y, et al. Among authors: fujiwara k. Sci Rep. 2023 Sep 7;13(1):14724. doi: 10.1038/s41598-023-41726-w. Sci Rep. 2023. PMID: 37679360 Free PMC article.
Retroperitoneoscopic Surgery in Children Does Not Cause Pathological Desaturation in Cerebral/Renal Oxygenation on Near-Infrared Spectroscopy Compared with Laparoscopic and Thoracoscopic Surgery.
Miyake Y, Fujiwara K, Kataoka K, Ochi T, Seo S, Koga H, Lane GJ, Nishimura K, Hayashida M, Yamataka A. Miyake Y, et al. Among authors: fujiwara k. J Laparoendosc Adv Surg Tech A. 2022 Dec;32(12):1260-1264. doi: 10.1089/lap.2022.0241. Epub 2022 Jul 29. J Laparoendosc Adv Surg Tech A. 2022. PMID: 35904967
Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report.
Nishii Y, Furuhashi K, Ito K, Sakaguchi T, Suzuki Y, Fujiwara K, Yasuma T, Kobayashi T, D'Alessandro-Gabazza CN, Gabazza EC, Taguchi O, Hataji O. Nishii Y, et al. Among authors: fujiwara k. Pharmaceuticals (Basel). 2022 Jul 19;15(7):889. doi: 10.3390/ph15070889. Pharmaceuticals (Basel). 2022. PMID: 35890187 Free PMC article.
45 results